Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
City of Hope Medical Center
City of Hope Medical Center
Zhejiang University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Stanford University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
University of Virginia
Loyola University